Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Debt / NOTE 0.625% 4/0
-
Number of holders
-
42
-
Total 13F principal, excl. options
-
316,716,637
-
Principal change
-
-11,748,803
-
Total reported value, excl. options
-
$256,209,800
-
Value change
-
-$13,969,327
-
Number of buys
-
18
-
Number of sells
-
18
-
Price
-
$0.8037
Institutional Holders of SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 as of Q1 2020
As of 31 Mar 2020 SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 had 42 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $316,716,637 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included ADVENT CAPITAL MANAGEMENT /DE/, CAMDEN ASSET MANAGEMENT L P /CA, Allianz Asset Management GmbH, WOLVERINE ASSET MANAGEMENT LLC, M&G INVESTMENT MANAGEMENT LTD, GOLDMAN SACHS GROUP INC, JPMORGAN CHASE & CO, Invesco Ltd., Radcliffe Capital Management, L.P., and STATE STREET CORP.
This table shows 43 bond principal holders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.